Malformin-a1 inhibits the binding of interleukin-1β (il1β) and suppresses the expression of tissue factor in human endothelial cells and monocytes-Reference-Cited by-同舟云学术

Malformin-a1 inhibits the binding of interleukin-1β (il1β) and suppresses the expression of tissue factor in human endothelial cells and monocytes

Published:1994-09 Issue:6 Volume:48 Page:1211-1217
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Herbert Jean-Marc,Savi Pierre,Lalé Alain,Laplace Marie-Claude,Baudry Nicole,Pereillo Jean-Marie,Emonds-Alt Xavier

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference47 articles.

1. Tissue factor and hemostasis;Nemerson;Blood,1988

2. Interleukin 1 induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells;Bevilacqua;J Exp Med,1984

3. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endo+helium: characterization and comparison with the action of interleukin 1;Bevilacqua,1986

4. Cultured human endothelial cells generate tissue factor in response to endotoxin;Colucci;J Clin Invest,1983

5. Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity;Nawroth,1986

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein tyrosine phosphatase 1B inhibitors from a marine-derived fungal strain aspergillus sp. SF-5929;Natural Product Research;2018-11-16

2. Preparations for Invasion: Modulation of Host Lung Immunity During Pulmonary Aspergillosis by Gliotoxin and Other Fungal Secondary Metabolites;Frontiers in Immunology;2018-11-06

3. Involvement of RSK1 activation in malformin-enhanced cellular fibrinolytic activity;Scientific Reports;2018-04-03

4. Therapeutic Antibody-Like Immunoconjugates against Tissue Factor with the Potential to Treat Angiogenesis-Dependent as Well as Macrophage-Associated Human Diseases;Antibodies;2018-01-23

5. Recent Advancements on the Role of Biologically Active Secondary Metabolites from Aspergillus;New and Future Developments in Microbial Biotechnology and Bioengineering;2018